ArticleCancer communications (London, England)2025

Neoadjuvant HER2 inhibition induces ESR1 DNA methylation alterations resulting in clinically relevant ER expression changes in breast cancers.

Gavin P Dowling et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.